Keynsham Hearing Centre
  • Facebook
  • Home
  • Testimonials
  • Video
    • Earwax Removal Keynsham
    • #615 (no title)
    • Ear syringing.. How it was
    • Hopi candle truth 2020
    • Unitron Hearing Aid
    • GN Sports Lock Retention Wire
    • Hearing Test Information
    • Fitting Hearing Aid Battery
  • Sound Proof Room
  • Hearing Aids
  • Noise Protection
  • Microsuction
  • Contact
  • News
  • Search
  • Menu
Hearing aids Bristol, News

Treatment of Ménière’s Disease and Vertigo

Keynsham Treatment of Ménière’s Disease and Vertigo

Treatment of Ménière’s Disease and Vertigo with Intranasal Betahistine

 

Treatment of Ménière’s Disease and Vertigo with Intranasal Betahistine

Auris MedicalAuris Medical Holding AG, a Swiss-based clinical-stage public company  (NASDAQ: EARS) dedicated to developing therapeutics in otolaryngology, has announced it will develop betahistine dihydrochloride in a spray formulation (with the product name AM-125) for the intranasal treatment of Ménière’s disease and vestibular vertigo. This represents the third clinical-stage development program to Auris Medical’s pipeline, and an expansion by the company into the field of vestibular disorders. Auris is also developing a drug for idiopathic sudden sensorineural hearing loss (ISSNHL, sudden hearing loss) and acute inner ear tinnitus.

“We are excited to add AM-125 to our development pipeline as it addresses important unmet medical needs in vestibular disorders and serves as a strategic fit with our existing projects,” said Auris Medical’s Founder, Chairman and CEO Thomas Meyer in a press statement. “While oral betahistine has been a mainstay treatment for Ménière’s disease and vestibular vertigo for many years and in many countries around the world, we expect the novel approach of intranasal delivery to offer significant additional benefits in terms of efficacy and tolerability.”

Auris Medical reports that it has entered into an agreement with Otifex Therapeutics Pty Ltd to purchase various assets related to intranasal betahistine, including preclinical and clinical data, as well as certain intellectual property rights. In a Phase 1 trial conducted by Otifex, intranasal betahistine showed good tolerance and a significantly higher bioavailability than reported for oral betahistine administration. Auris Medical plans to initiate a second Phase 1 trial in 2017.

“As our treatment options for vestibular disorders are currently very limited in the United States, I am pleased to see that betahistine will be developed as a treatment for patients here who are suffering from Ménière’s disease or vestibular vertigo,” said Lawrence R. Lustig, MD, Chair, Department of Otolaryngology at Columbia University Medical Center in the press release. “The compound has an established track record for safety, and the clinical experience suggests that it may help control or ease vertigo attacks in Ménière’s disease. It will be exciting to have a new treatment for this disabling condition.”

According to Auris Medical, Betahistine is a small molecule drug that acts as a partial histamine H1-receptor agonist and a H3-receptor antagonist. The compound has demonstrated increased cochlear, vestibular, and cerebral blood flow, vestibular compensation, and the ability to inhibit neuronal firing in the vestibular nuclei.

Oral betahistine is approved for the treatment of Ménière’s disease and vestibular vertigo in more than 80 countries worldwide, and has been reportedly prescribed more than 130 million patients. However, betahistine has not been approved for marketing in the United States for the past few decades.

The brand Serc (betahistine) was approved by the FDA in the early 1970s as vestibular suppressant for Ménière’s disease, but that approval was withdrawn after about 5 years. Primarily, the drug has had issues surrounding its clinical trials and subsequent proof of efficacy. Even though studies have shown betahistine effective against vertigo attacks, most of these studies have been criticized for design flaws. The Cochrane Library concluded in 2001 that “Most trials suggested a reduction of vertigo with betahistine and some suggested a reduction in tinnitus but all these effects may have been caused by bias in the methods. One trial with good methods showed no effect of betahistine on tinnitus compared with placebo in 35 patients. None of the trials showed any effect of betahistine on hearing loss. No serious adverse effects were found with betahistine.”

Update on Auris Medical Tinnitus Trials

Auris Medical also announced last week that it has resumed patient enrollment in the TACTT3 Phase 3 trial of Keyzilen® (AM-101) in acute and post-acute inner ear tinnitus. According to Reuters, the company experienced a set-back in August when the drug missed the main goals of a late-stage study by failing to meet the two co-primary effectiveness goals of statistically significant changes in tinnitus loudness and tinnitus burden compared to a placebo.

“Following the swift approval by regulatory agencies and ethics committees, we are pleased to resume enrollment under the amended protocol in the TACTT3 Phase 3 clinical trial of Keyzilen,” said Meyer. “We have applied key learnings from the TACTT2 trial that we believe substantially strengthen TACTT3’s probability of success, and we look forward to top-line results in early 2018.”

TACTT3, which is being conducted in Europe, is a randomized, double-blind, placebo-controlled Phase 3 trial in inner ear tinnitus following traumatic cochlear injury or otitis media. The trial previously enrolled more than 300 patients during the acute tinnitus stage (Stratum A) and approximately 330 patients during the post-acute tinnitus stage (Stratum B). As previously announced, the TACTT3 protocol was amended based on analysis of the TACTT2 Phase 3 trial outcomes. The amended protocol elevates the Tinnitus Functional Index score from a key secondary endpoint to an alternate primary efficacy endpoint, includes certain patient subgroups in confirmatory statistical testing, and increases the trial size with the enrollment of an additional 60 patients in each of Stratum A and B.

22nd June 2020/by admin
https://keynshamhearing.co.uk/wp-content/uploads/2020/06/Honiton-hearing-Treatment-of-Ménière’s-Disease-and-Vertigo-with-Intranasal-Betahistine-.jpg 528 620 admin https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png admin2020-06-22 13:36:222020-06-22 13:36:22Treatment of Ménière’s Disease and Vertigo
Hearing aids Bristol, News

IHear Medical Launches Free @Home Hearing Test

Bath Hearing centre

IHear Medical Launches Free @Home Hearing Test

   

IHear Medical Launches Free @Home Hearing Test

iHEAR Medical announced the launch of the Free @Home iHEARtest campaign, offering consumers the ability to test their hearing for free at home with the “only FDA approved home hearing screener.” The iHEARtest is said to “rapidly profile hearing ability based on guidelines by the World Health Organization (WHO).”

Keynsham Hearing centre

“The Free @Home test addresses compromised hearing care during the unfolding COVID-19 pandemic,” said Adnan Shennib, Founder and CEO of iHEAR Medical.

The iHEARtest kit includes “factory calibrated earphones” to ensure accuracy of test results, according to the company. The Free @Home iHEARtest can be ordered online or by phone (1-844-443-2744, Toll-Free) for delivery directly to the customer’s home. Customers pay $9 to cover the cost of two-way shipping and handling, and have 30 days to take the iHEARtest and return it using the provided pre-paid return label and packaging.

Bristol hearing shop

According to iHEAR Medical, the iHEARtest was approved by the FDA following years of clinical research demonstrating safety and accuracy. Additionally, clinical studies under the oversight of an independent Institutional Review Board (IRB) have shown the iHEARtest’s “ease of self-use, accuracy and 96.4% agreement with standard practice audiometry for the assessment of normal versus disabling hearing impairment.”

Source: iHEAR Medical

17th June 2020/by admin
https://keynshamhearing.co.uk/wp-content/uploads/2020/06/Bristol-hearing-aids-.jpg 320 600 admin https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png admin2020-06-17 10:02:352020-06-17 10:02:35IHear Medical Launches Free @Home Hearing Test
Ear wax removal Keynsham Bristol, News

CEVA and Bragi Partner on Hearable Devices

Keynsham hearing centre

CEVA and Bragi Partner on Hearable Devices

CEVA and Bragi Partner on Hearable Devices

CEVA, Inc (NASDAQ: CEVA), a licensor of wireless connectivity and smart sensing technologies, and Bragi GmbH, a technology company based in Munich, Germany, announced a strategic collaboration to drive a new class of hearable devices where the user experience is “customizable via the industry’s first hearable app store.” Target devices include headsets, hearing aids, True Wireless Stereo (TWS) earbuds, and a host of other smart audio devices for the consumer and the smart home.

Honiton hearing wearables

According to the companies’ announcement, the partnership takes advantage of the low power, CEVA-BX DSP architecture, along with its LLVM compiler and Eclipse based development tool chain, and Bragi 4, a newly defined operating system (OS) specialized for hearables. In conjunction with Bragi 4 OS, Bragi’s patented commercial app store will “help enable technology partners and experts to offer software apps and services such as voice activation, voice biometric, audio post processing, and music services.” These software packages can be licensed and downloaded directly to devices based on this architecture, allowing individuals to personalize their hearables user experience. CEVA will also offer a range of its value-added software via the Bragi app store, including ClearVox for noise reduction, WhisPro for speech recognition, MotionEngine for sensor fusion, and the SenslinQ framework for contextual awareness.

“Imagine buying headphones that adapt according to the needs of the user. Purchase noise-canceling software just before boarding a plane,” said Nikolaj Hviid, Founder and CEO of Bragi. “Encrypt communication data for sensitive business conversations. Discover that you hear better with voice amplification through try-to-buy offers. On business travel, use your headphones to translate from Chinese into English. Add a feature that alerts someone if your headphones detect you’ve fallen over. The possibilities are endless.”

Through this collaboration, “hearables and other smart audio devices will transform in the same way as the mobile phone industry in the ’00s, by replacing single-purpose feature products with flexible products capable of adapting their functionalities to the users through post-purchase apps and services.”

“Our collaboration with Bragi brings a game-changing approach to the design of hearables and other audio devices, where the user experience can be adapted, instantaneously,” said Moshe Sheier, Vice President of Marketing at CEVA. “Our CEVA-BX audio DSPs, voice processing and motion sensing software, and SenslinQ context-aware framework perfectly complement Bragi’s OS and unique capabilities in providing a direct channel for OEMs and ODMs to offer a customizable user experience to consumers through enhanced software and services.”

For customers wishing to integrate wireless connectivity into their SoC design, CEVA provides Bluetooth, Wi-Fi, and NB-IoT solutions, including the latest Bluetooth LE Audio standard. Any of these technologies can be seamlessly integrated into a SoC design and linked together with the audio offerings via the SenslinQ framework. For further information, visit: https://www.ceva-dsp.com/product/ceva-senslinq/.

Source: CEVA, Bragi GmbH

Images: CEVA, Bragi GmbH

8th June 2020/by admin
https://keynshamhearing.co.uk/wp-content/uploads/2020/06/Ceva.jpg 400 400 admin https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png admin2020-06-08 09:53:552020-06-08 09:58:26CEVA and Bragi Partner on Hearable Devices
Hearing aids Bristol, News

ChatableApps Launches ‘Universal Hearing Aid’

Ear wax removal Bristol

ChatableApps Launches ‘Universal Hearing Aid’

 

ChatableApps announced the launch of “the world’s first universal hearing aid, using neuroscience-led artificial intelligence to enable those suffering from hearing loss to hear one-to-one conversations clearly, using an everyday smartphone and a standard pair of earbuds.”

Hearing loss affects 37.5 million adults in the US* and the World Health Organization (WHO) has stated that 466 million** people globally have ‘disabling hearing loss,’ with this expected to reach 900 million by 2050. However, due to the high cost of traditional hearing aids and lack of inclusion in medical insurance, many of those suffering are currently going untreated.

Ear wax removal Bristol
Chatable Hearing Aid (Photo: Business Wire)

Serial entrepreneur Mark Cuban, who provided early investment in the technology, said: “Chatable is using AI to address growing health care inequality by providing an affordable hearing aid app that helps with conversation.”

Founder and chief scientist at ChatableApps, Dr Andrew Simpson (PhD) has devised a “brand-new way of thinking about AI which reverse engineers the neural processes of the hearing brain and implements them as AI,” according to the company’s announcement.

“Putting an auditory cortex on a smartphone has been a dream for a long time. As far as I know, this is the most advanced real-time AI that has ever gone on a phone,” said Simpson. “It’s been a long road, but our preclinical trials reveal something of a medical breakthrough: A hearing aid that doesn’t need hearing tests and going straight into the hands of people who can’t afford a hearing aid.”

The performance levels Simpson’s approach achieves reportedly “surpass those of a traditional hearing aid when it comes to one-to-one conversation.” The company says this was confirmed in pre-clinical trials where “86% reported that the ChatableApps universal hearing aid was better for conversation than their traditional hearing aid.”

Despite the complex science and AI at work in the app, the company describes its user interface as “simple.”  Once downloaded, the user moves two sliders up and down to find their desired balance. The volume boost slider helps enable “clear and loud voice, while the background noise slider removes background noise, allowing users to hear conversations no matter where they are.”

“Our unique ground-up AI makes our universal hearing aid the first app capable of addressing the global hearing epidemic,” said Giles Tongue, ChatableApps CEO. “Following successful preclinical trials, we have decided to launch immediately due to urgent demand from audiologists to help people struggling because of coronavirus. With many unable to lip-read due to face masks or unable to visit a hearing clinic in an emergency, our app provides a lifeline that will help people communicate.”

The ChatableApps Universal Hearing Aid app is available to download now on iOS and Android. The app is free to access, with the option to subscribe to unlock maximum voice amplification and reduction of background noise. The full version is available for $12.99 /monthly, $79.99 /annual.

iOS: https://apps.apple.com/gb/app/chatable-hearing-aid/id1494968908 
Android: https://play.google.com/store/apps/details?id=com.hearingaid.volumebooster&hl=en_GB

*Figures taken from – https://www.nidcd.nih.gov/health/statistics/quick-statistics-hearing 
**Taken from the World Health Organization’s ‘Global estimates on prevalence of hearing loss’ (2018)

In pre-clinical trials:

● 76% said conversation was easier because of our background noise slider, 15% in a life changing way;

● 80% said conversation was easier because of our volume boost (and that was before we beefed it up), 15% in a life-changing way;

● 86% reported app was better for conversation than their hearing aid.

Source: ChatableApps

Images: ChatableApps, Business Wire

1st June 2020/by admin
https://keynshamhearing.co.uk/wp-content/uploads/2020/06/ChatableApps-1.jpg 480 480 admin https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png admin2020-06-01 10:44:522020-06-01 11:03:13ChatableApps Launches ‘Universal Hearing Aid’
Bath hearing loss centre, Hearing aids Bristol, News

Starkey announces..

Keynsham hearing centre

Starkey announces..

Keynsham hearing centre

Starkey hearing aids at the Keynsham hearing centre

Starkey announced that “the world’s first 2.4 GHz custom rechargeable hearing aids” are now available in all configurations and colours.

“We are proud to continue offering industry-leading technology even in this time of disruption,” said Starkey President Brandon Sawalich. “We want to thank our valued partners for their continued business and the opportunity to provide hearing health care to you and your patients. We sincerely appreciate the work you do and are maintaining 98% on-time delivery. How we work is changing, but our mission is the same: to serve our customers better than anyone else.”

To learn more about Starkey’s ground-breaking custom rechargeable hearing aids, please click here.

 

All Starkey hearing aids are available at the Keynsham hearing centre Somerset

Source: Starkey

28th April 2020/by admin
https://keynshamhearing.co.uk/wp-content/uploads/2020/04/Keynsham-hearing.jpg 417 640 admin https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png admin2020-04-28 18:34:192020-04-28 18:34:19Starkey announces..
Hearing aids Bristol, News

Moxi Jump R

Keynsham hearing centre

Unitron Wins 2020 Red Dot Product Design Award for Moxi Jump R

 

Keynsham hearing centre

Bristol hearing aids

Unitron, a Canadian hearing aid manufacturer, announced that it has won the “Red Dot: Product Design 2020” award for its Moxi Jump R hearing aids. The Moxi Jump R helps provide hearing aid wearers with “easy-to-use technology that automatically adapts to a user’s listening environment.”

The Red Dot Award, which dates to 1955, celebrates “excellence in product design.” This marks the sixth time Unitron has received the Red Dot Award for its inventive hearing instruments.

“To be recognized with this award from a pool of incredible designs is a tremendous honor,” says Sandra Fulton, Unitron Vice President of Global Marketing. “It clearly demonstrates our global leadership in hearing instrument design from the engineering and optimization of features and performance to the final product.”

Launched in 2019, the sound processing system in the Moxi Jump R uses machine learning, a branch of artificial intelligence, to “automatically recognize, classify, and adjust sounds based on the user’s listening environments.” This includes seven different listening environments that span quiet, conversation in quiet, conversation in noise, and music.

The Moxi Jump R also helps allow users to connect to Apple and Android devices and participate in hands-free phone calls, video calls, and media streaming to both ears. The rechargeable lithium-ion battery provides 24 hours of amplification, or 16 hours of amplification with 8 hours of media streaming.

“Our user-centric design philosophy is based on the premise that our technology should be easy-to-use and provide optimal sound performance to allow people overcoming hearing loss to reconnect with their lives, their loved ones, and everything in between,” said Banham. “The Moxi Jump R makes this possible, combining aesthetics, comfort, and intuitive functionality into one cutting-edge device.”

The Moxi Jump R can be controlled through the Remote Plus app, which allows hearing aid wearers to control volume, adjust balance, and share real-time impressions of their hearing instruments using their smartphones, according to the company. The app also helps enable clients to connect with their hearing care professionals via cloud technology. The Coach feature on the Remote Plus app sends users notifications for when to charge their batteries, clean their devices, usage details, and much more.

“As we shift to a more technologically-savvy consumer base, our products have to provide users with a range of functionality while optimizing sound performance and user experience. The Red Dot award is further recognition that Unitron is leading the way in the hearing health space,” said Banham.

The international Red Dot jury is made up of 40 independent design experts, educators, and industry journalists who review thousands of submissions annually from manufacturers and product designers around the world. Products are evaluated based on quality, performance, degree of innovation, and ecological compatibility.

Award winners will be celebrated at the annual Red Dot award gala, which takes place in the Aalto Theater in Essen, Germany.

Source: Unitron

20th April 2020/by admin
https://keynshamhearing.co.uk/wp-content/uploads/2020/04/Bristol-hearing-aids.jpg 427 640 admin https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png admin2020-04-20 17:23:402020-04-20 17:23:40Moxi Jump R
Hearing aids Bristol, News

The Challenge of BTE Hearing Aids with Masks

The Challenge of BTE Hearing Aids with Masks

    

The Challenge of BTE Hearing Aids with Masks

Wearing masks have become common practice during the COVID-19 pandemic. For people who use behind-the-ear (BTE) hearing aids, however, this may be uncomfortable, according to a blog posting by audiologist Sheri Gostomelsky on the ChicagoNow website.

Gostomelsky suggests several creative solutions to the problem which include putting your hair in a bun and looping the elastic around the bun itself; sewing buttons onto a headband that the mask loops over; creating an extension for the mask, and sewing or purchasing a mask with ties instead of elastic.

To read the posting in its entirely, please click here. Hearing Review also recently published a study by Goldin, Weinstein, and Shiman about how medical masks essentially functioned as a low-pass acoustic filter for speech, attenuating the high frequencies (2000-7000 Hz) spoken by the wearer by 3 to 4 dB for a simple medical mask and close to 12 dB for the N95 masks.

Source: ChicagoNow

15th April 2020/by admin
https://keynshamhearing.co.uk/wp-content/uploads/2020/04/Bristol-hearing.jpg 320 640 admin https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png admin2020-04-15 14:05:452020-04-15 14:05:45The Challenge of BTE Hearing Aids with Masks
Hearing aids Bristol, News

Starkey Expands Remote Programming Feature to More Hearing Aid Users

Keynsham hearing centre

Starkey Expands Remote Programming Feature to More Hearing Aid Users

 

Starkey Expands Remote Programming Feature to More Hearing Aid Users

In response to the ongoing challenges facing hearing care providers and their patients amid the COVID-19 pandemic, Starkey announced that it has made telehealth technology available to “even more hearing aid users.” Effective immediately, ‘Hearing Care Anywhere’ remote programming is now enabled across all technology tiers of Starkey’s Livio, Livio AI, and Livio Edge AI hearing aids. The change is said to allow more patients to receive care from their homes and gives hearing professionals the ability to conduct appointments despite social distancing.

“This is a very difficult time for the majority of us in the hearing industry,” said Starkey President Brandon Sawalich. “When we developed the Hearing Care Anywhere remote programming feature, we knew it would provide hearing healthcare providers with added convenience and efficiency, but we never imagined the important role it would play in such an unprecedented situation. We are so proud that our relentless dedication to staying on the cutting-edge of hearing technology is helping patients hear better at a time when clear communication is so critical.”

Through this latest update, even patients whose devices were not originally configured for remote programming are now able to access this feature. Using the Thrive app, patients can send requests to their hearing providers, who are then able to make fine-tuning adjustments to optimize hearing aid performance remotely. This new measure enhances patient safety by reducing the need for an in-office visit.

“For many clinics, up to 30% of appointments are for minor adjustments,” said Starkey’s Chief Innovation Officer Dave Fabry, PhD. “In the past, clinicians needed to initiate remote programming via the Inspire software during face-to-face visits. Today, those adjustments can be handled remotely through Hearing Care Anywhere.”

“Since early on during the COVID-19 pandemic, we’ve had to balance the dilemma of protecting our patients while ensuring their hearing devices are performing optimally,” said Terence Limb, AuD, of Kirkland, Wash. “In the past, we didn’t always enable Hearing Care Anywhere in Inspire. This update enables me to continue to engage with patients during this difficult time. Moreover, it will change the way that we can better serve patient needs in the future.”

For more information on these new updates to Hearing Care Anywhere remote programming, please click here.

Source: Starkey

Keynsham hearing centre

Starkey hearing aids at the Keynsham hearing centre

7th April 2020/by admin
https://keynshamhearing.co.uk/wp-content/uploads/2020/04/Keynsham-hearing.jpg 417 640 admin https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png admin2020-04-07 13:40:562020-04-07 13:40:56Starkey Expands Remote Programming Feature to More Hearing Aid Users
News, Tinnitus therapy

Tinnitus Therapy Somerset

Keynsham hearing centre

Tinnitus Therapy Somerset

 

Today we are looking at something a lot of people have to deal with on a daily and nightly basis. We are talking about Tinnitus.

Below is a link to the BBC News website which shows a musician living with Tinnitus and how he changed the way he dealt with it.

Here at Keynsham hearing we can help you with Tinnitus, but only when the Covid19 is behind us and we are once again open.

Isle of Wight musician fights tinnitus with soundscapes

When musician Rupert Brown developed tinnitus aged 22 he thought his life was completely over.

However, by mixing the noise of his tinnitus with natural sounds and music to create a soundscape, he says he’s reduced the noise he hears.

He’s now helping others on the Isle of Wight where he lives.

Tinnitus is the sensation of hearing a sound in the absence of any external sound. One in eight have persistent tinnitus, according to the British Tinnitus Association.

Somerset Tinnitus therapy

Somerset Tinnitus therapy

You can see more on Rupert’s story on BBC Inside Out South on BBC iPlayer here.

31st March 2020/by admin
https://keynshamhearing.co.uk/wp-content/uploads/2020/03/Tinnitus-Devon.jpg 427 640 admin https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png admin2020-03-31 17:32:292020-03-31 17:32:29Tinnitus Therapy Somerset
Bath ear wax removal, Ear wax removal Bristol, News

Phonak Launches Naída Marvel (M)

Bath hearing centre

Phonak Launches Naída Marvel (M)

 

Bath hearing centre 

Phonak announced the launch of the Naída Marvel (M), described as “a fully-connected, multifunctional super-power hearing aid for those with severe-to-profound hearing loss.” Naída Marvel reportedly delivers “rich, powerful sound and directly connects to virtually any Bluetooth device including smartphones, TVs, tablets, PCs, and much more,” according to Phonak. Integrated Marvel 2.0 technology like RogerDirect helps give wearers the flexibility to stream the Roger signal directly into both ears, resulting in almost 10x better-than-normal hearing in noisy situations and over distance.1 

Naída M: Power meets connectivity

Naída M is said to be “the world’s first super power hearing aid that directly connects to both iOS and Android, or virtually any other Bluetooth enabled audio device.” It’s also reportedly “the world’s only super-power hearing aid to allow hands-free phone conversations as well as the classification of streamed audio signals.” 2 With Naída M, super power wearers can use their hearing aids like wireless headsets, according to Phonak.

“Since the release of its first power hearing aid in 1978, the Phonak brand has been dedicated to creating powerful hearing solutions that deliver excellent hearing performance,” said Jon Billings, Vice President of Marketing at Phonak. “Now in its sixth generation, Naída M builds on this legacy with award-winning Marvel technology. The result is Naída becoming the most powerful Super Power3 multifunctional hearing solution that allows people with severe-to-profound hearing loss to connect to everyone and everything around them.”

Extending Marvel and increasing accessibility 

Per the World Health Organization (WHO), approximately 466 million people worldwide have disabling hearing loss.4 Left untreated, these individuals have extreme difficulty communicating with others, often relying on lip reading and/or sign language.5 One study found the societal costs of this degree of hearing loss in the US alone to be nearly $300,000 over the lifetime of each person, most of this attributed to reduced work productivity.6

Naída M’s combination of power with wireless connectivity was specifically engineered to address the unique communication needs of people with severe forms of hearing loss, Phonak says. According to the company’s announcement, StereoZoom helps to reduce listening effort in noise by 24% versus a non-directional program and even enhances memory recall with 10% more words recalled in noise.7 NaídaMarvel directly connects to Roger microphones to help improve speech understanding in noise and over distance1 while remaining 15% smaller and 14% lighter than previous versions that required an external receiver.

Finally, the myCall-to-Text app helps provide live transcription of phone calls from the other party in more than 80 languages. This is an ideal solution for people who would like to benefit from additional visual captions when using the phone.

Naída Marvel will be available to the public at the end of February through licensed hearing care professionals. For more information, please visit http://www.phonak.com/naidamarvel.

  1. Thibodeau L. Comparison of speech recognition with adaptive digital and FM remote microphone hearing assistance technology by listeners who use hearing aids. American Journal of Audiology. 2014;23(2):201-210.
  2. Rodrigues T, Liebe S. Phonak. AutoSense OS™ 3.0. The new & enhanced automatic operating system. https://www.phonakpro.com/content/dam/phonakpro/gc_ca/en/products_solutions/hearing_aid/Audeo_M/documents/Insight_btb_Audeo_Marvel_AutoSense_OS_30.pdf. Published July 2018.
  3. Phonak. Phonak NaídaTM M Technical Data. https://www.phonakpro.com/content/dam/phonakpro/gc_hq/en/products_solutions/hearing_aid/naida_marvel/documents/datasheet_naida_marvel_sp.pdf. Accessed January 13, 2020.
  4. Deafness and hearing loss fact sheet. World Health Organization (WHO). https://www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss. Published March 20, 2019.
  5. European Working Group on Genetics of Hearing Impairment. Biomedical and Health Research Programme (HEAR) Infoletter 2. November 1996; 8.
  6. Mohr PE, Feldman JJ, Dunbar JL, et al. The societal costs of severe to profound hearing loss in the United States. International Journal of Technology Assessment in Health Care. 2000;16(04):1120-1135.
  7. Winneke A, Schulte M, Latzel M. The effect of spatial noise processing in hearing aids on neural correlates of listening and memory effort: An EEG study. 2019. Manuscript in preparation.

Bluetooth® word mark is a registered trademark owned by Bluetooth SIG, Inc. and any use of such mark by Sonova AG is under license.

IOS is a trademark of Cisco Technology, Inc.

Android is a trademark of Google LLC.

Source: Phonak

Images: Phonak

24th March 2020/by admin
https://keynshamhearing.co.uk/wp-content/uploads/2020/03/Keynsham-hearing-Somerset.jpg 480 640 admin https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png admin2020-03-24 12:40:562020-03-24 12:40:56Phonak Launches Naída Marvel (M)
Page 2 of 41234

Categories

  • Bath ear wax removal
  • Bath hearing loss centre
  • Ear wax removal Bristol
  • Ear wax removal Keynsham Bristol
  • Hearing aids Bath
  • Hearing aids Bristol
  • Hearing loss
  • Hearing test Bristol
  • News
  • Tinnitus therapy
  • Uncategorised

Latest News

  • 40 Years of hearing aid Sound Processing7th June 2021 - 9:38 am
  • ‘Forbes’ Journalist Tries Widex Moment Hearing Aids1st June 2021 - 3:30 pm
  • Bath hearing centre, Bristol hearing centre, Frome hearing centre,,Phonak Launches Naida Paradise Hearing Aid21st May 2021 - 2:42 pm
  • Ear Drum Scaffolding8th May 2021 - 3:55 pm
  • Oticon More Keynsham Hearing3rd May 2021 - 6:09 pm

Interesting Fact

A person with hearing loss will always have hearing loss, but with hearing aids they can learn to communicate more easily. Hearing aids provide a way for those who are hard of hearing to improve their quality of life.

Keynsham Hearing Centre

34 Temple Street, Keynsham,
BS31 1EH

Call us now on 0117 986 4242

email: info@keynshamhearing.co.uk

Working Hours

Monday: 9AM – 4PM
Tuesday: 9AM – 4PM
Wednesday: 9AM – 4PM
Thursday: 9AM – 4PM
Friday: Closed
Saturday: By Appointment only
Sunday: Closed
Bank holidays: Closed

Latest News

  • 40 Years of hearing aid Sound Processing7th June 2021 - 9:38 am
  • ‘Forbes’ Journalist Tries Widex Moment Hearing Aids1st June 2021 - 3:30 pm
  • Bath hearing centre, Bristol hearing centre, Frome hearing centre,,Phonak Launches Naida Paradise Hearing Aid21st May 2021 - 2:42 pm
  • Ear Drum Scaffolding8th May 2021 - 3:55 pm
© Copyright 2019-2024 Keynsham Hearing Centre - Powered by creativeminds.co.uk
  • Facebook
Scroll to top

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Keynsham Hearing Centre
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.